Literature DB >> 27618681

Early Identification of Patients With Out-of-Hospital Cardiac Arrest With No Chance of Survival and Consideration for Organ Donation.

Patricia Jabre1, Wulfran Bougouin1, Florence Dumas1, Pierre Carli1, Corinne Antoine1, Laurent Jacob1, Benjamin Dahan1, Frankie Beganton1, Jean-Philippe Empana1, Eloi Marijon1, Nicole Karam1, Alexandre Loupy1, Carmen Lefaucheur1, Daniel Jost1, Alain Cariou1, Frédéric Adnet1, Thomas D Rea1, Xavier Jouven1.   

Abstract

BACKGROUND: In patients with out-of-hospital cardiac arrest (OHCA), care requirements can conflict with the need to promptly focus efforts on organ donation in patients who are pronounced dead.
OBJECTIVE: To evaluate objective criteria for identifying patients with OHCA with no chance of survival during the first minutes of cardiopulmonary resuscitation to enable prompt orientation toward organ donation.
DESIGN: Retrospective assessment using OHCA data from 2 registries and 1 trial.
SETTING: France (Paris Sudden Death Expertise Center [SDEC] prospective cohort [2011 to 2014] and PRESENCE multicenter cluster randomized trial [ClinicalTrials.gov: NCT01009606] [2009 to 2011]) and the United States (King County, Washington, prospective cohort [2006 to 2011]). PATIENTS: 1771 patients from the Paris SDEC 1-year cohort (2011 to 2012) and 5192 from the validation cohorts. MEASUREMENTS: Evaluation of 3 objective criteria (OHCA not witnessed by emergency medical services personnel, nonshockable initial cardiac rhythm, and no return of spontaneous circulation before receipt of a third 1-mg dose of epinephrine), survival rate at hospital discharge among patients meeting these criteria, performance of the criteria, and number of patients eligible for organ donation.
RESULTS: In the Paris SDEC 1-year cohort, the survival rate among the 772 patients with OHCA who met the objective criteria was 0% (95% CI, 0.0% to 0.5%), with a specificity of 100% (CI, 97% to 100%) and a positive predictive value of 100% (CI, 99% to 100%). These results were verified in the validation cohorts. Ninety-five (12%) patients in the Paris SDEC 1-year cohort may have been eligible for organ donation. LIMITATION: Several patients had unknown outcomes.
CONCLUSION: Three objective criteria enable the early identification of patients with OHCA with essentially no chance of survival and may help in decision making about the organ donation process. PRIMARY FUNDING SOURCE: French Ministry of Health.

Entities:  

Mesh:

Year:  2016        PMID: 27618681     DOI: 10.7326/M16-0402

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  5 in total

Review 1.  Organ donation after circulatory death: current status and future potential.

Authors:  Martin Smith; B Dominguez-Gil; D M Greer; A R Manara; M J Souter
Journal:  Intensive Care Med       Date:  2019-02-06       Impact factor: 17.440

2.  Organ donation after resuscitation from cardiac arrest.

Authors:  Jonathan Elmer; Bradley J Molyneaux; Kurt Shutterly; Susan A Stuart; Clifton W Callaway; Joseph M Darby; Amy R Weisgerber
Journal:  Resuscitation       Date:  2019-10-22       Impact factor: 5.262

3.  DHA-supplemented diet increases the survival of rats following asphyxia-induced cardiac arrest and cardiopulmonary bypass resuscitation.

Authors:  Junhwan Kim; Tai Yin; Koichiro Shinozaki; Joshua W Lampe; Lance B Becker
Journal:  Sci Rep       Date:  2016-11-04       Impact factor: 4.379

4.  Early predictors of poor outcome after out-of-hospital cardiac arrest.

Authors:  Louise Martinell; Niklas Nielsen; Johan Herlitz; Thomas Karlsson; Janneke Horn; Matt P Wise; Johan Undén; Christian Rylander
Journal:  Crit Care       Date:  2017-04-13       Impact factor: 9.097

5.  An increased potential for organ donors may be found among patients with out-of-hospital cardiac arrest.

Authors:  Mads Anders Rasmussen; Håvard Storsveen Moen; Louise Milling; Sune Munthe; Christina Rosenlund; Frantz Rom Poulsen; Anne Craveiro Brøchner; Søren Mikkelsen
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2022-08-17       Impact factor: 3.803

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.